- Home
- ACHV vs ESOA Comparison
ACHV vs ESOA Comparison
Compare ACHV & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- ESOA
- Stock Information
- Founded
- ACHV N/A
- ESOA 2006
- Country
- ACHV United States
- ESOA United States
- Employees
- ACHV N/A
- ESOA N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ESOA Water Sewer Pipeline Comm & Power Line Construction
- Sector
- ACHV Health Care
- ESOA Industrials
- Exchange
- ACHV Nasdaq
- ESOA Nasdaq
- Market Cap
- ACHV 153.8M
- ESOA 165.3M
- IPO Year
- ACHV N/A
- ESOA 2006
- Fundamental
- Price
- ACHV $3.15
- ESOA $9.99
- Analyst Decision
- ACHV Strong Buy
- ESOA Strong Buy
- Analyst Count
- ACHV 2
- ESOA 1
- Target Price
- ACHV $16.00
- ESOA $21.00
- AVG Volume (30 Days)
- ACHV 867.2K
- ESOA 132.0K
- Earning Date
- ACHV 11-06-2025
- ESOA 08-11-2025
- Dividend Yield
- ACHV N/A
- ESOA 1.20%
- EPS Growth
- ACHV N/A
- ESOA N/A
- EPS
- ACHV N/A
- ESOA 0.17
- Revenue
- ACHV N/A
- ESOA $385,589,109.00
- Revenue This Year
- ACHV N/A
- ESOA $13.08
- Revenue Next Year
- ACHV N/A
- ESOA $3.54
- P/E Ratio
- ACHV N/A
- ESOA $59.43
- Revenue Growth
- ACHV N/A
- ESOA 9.52
- 52 Week Low
- ACHV $1.84
- ESOA $7.64
- 52 Week High
- ACHV $5.31
- ESOA $19.83
- Technical
- Relative Strength Index (RSI)
- ACHV 56.75
- ESOA 47.49
- Support Level
- ACHV $3.07
- ESOA $9.75
- Resistance Level
- ACHV $3.21
- ESOA $10.61
- Average True Range (ATR)
- ACHV 0.14
- ESOA 0.44
- MACD
- ACHV 0.01
- ESOA -0.00
- Stochastic Oscillator
- ACHV 77.55
- ESOA 28.28
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About ESOA Energy Services of America Corporation
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.